Brind.

Mesoblast, founded by Dr. Silviu Itescu in 2004, is currently seeking product approval and market access in Europe while trading on the Nasdaq stock exchange.

2 reports, 1 independent Updated Sep 13

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Mesoblast, founded by Dr. Silviu Itescu in 2004, is currently seeking product approval and market access in Europe while trading on the Nasdaq stock exchange.

Who's involved

What this event is mainly about

Mesoblast Europe Nasdaq

Keep exploring

The entities involved

Mesoblast
pharmaceutical company

Nothing else this week.
Europe
terrestrial continent located in north-western Eurasia
- Alberta debates its future within Canada amid broader European protests and civil unrest.03:47
- The article discusses the likelihood of Alberta becoming the 51st US state and explains the cause of riots in Europe.03:43
Nasdaq
American fully electronic stock exchange
- Houthis attacks in Saudi Arabia prompt US diplomatic action, while quarterly results improve investor appetite.03:32
- Direct Digital is voluntarily delisting from Nasdaq following SEC regulatory actions.01:29

Coverage

Newest first; wire copies grouped

Sep 13themarketsdaily.com
Aug 10themarketsdaily.com